Market Alert : US-Iran reach peace deal: Is this a good sign for global markets?

Atlas Arteria Lodges Third Supplementary Target’s Statement, Reiterates Rejection of IFM Offer

Atlas Arteria (ASX: ALX) has lodged its Third Supplementary Target’s Statement with the Australian Securities and Investments Commission (ASIC) and the ASX in response to IFM Global Infrastructure Fund’s off-market takeover offer through Diamond Infraco 1 Pty Ltd. The document supplements the company’s original Target’s Statement and subsequent updates issued in early June 2026. Atlas Arteria’s Independent Directors have again unanimously recommended that securityholders reject the offer, arguing that it does not adequately reflect the intrinsic value of the company or provide an appropriate control premium.

The company stated that the revised offer price of AU$5.10 per security remains below the midpoint of the independent expert’s valuation range and undervalues several of its infrastructure assets. Atlas Arteria also reaffirmed its 2026 ordinary distribution guidance of 40.0 cents per security and highlighted that proceeds from potential asset sales, including its Chicago Skyway stake, could provide additional returns to investors. Management further noted that IFM has historically increased takeover offers in similar transactions and maintained that securityholders have no immediate reason to accept the current proposal.

 

 

Customer Notice:

Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.

Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com.au